Cape Investment Advisory’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Cape Investment Advisory’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-60	Closed	-$8.78K	–	1148
2023 Q3	$8.78K	Hold	60	–	–	0.01%	577
2023 Q2	$9.19K	Hold	60	–	–	0.01%	568
2023 Q1	$9.3K	Buy	+60	New	+$9.42K	0.01%	553

Other funds holding FBT

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Cape Investment Advisory's FBT Position: Q4 2023 in Review

Cape Investment Advisory sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q4 2023, closing a stake of 60 shares — an estimated $8.78K sold.

Cape Investment Advisory first reported a position in FBT in Q1 2023 and held it in 3 quarters. The position peaked at $9.3K in Q1 2023. 257 funds tracked by Wall St. Rank hold FBT as of Q4 2023.

Cape Investment Advisory reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q4 2023 after selling out during the quarter.
Cape Investment Advisory sold 60 First Trust NYSE Arca Biotechnology Index Fund shares in Q4 2023, an estimated $8.78K.
Cape Investment Advisory first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2023 and held it in 3 quarters.
Cape Investment Advisory's First Trust NYSE Arca Biotechnology Index Fund position peaked at $9.3K in Q1 2023.
257 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q4 2023.

Based on Cape Investment Advisory's 13F filing for Q4 2023, filed 12 Feb 2024.